Nandini Kashyap

Title: Nandini Kashyap: Innovator in Insulin Formulation

Introduction

Nandini Kashyap is a prominent inventor based in Danbury, CT (US). She has made significant contributions to the field of diabetes management through her innovative work in insulin formulations. Her dedication to improving patient care is evident in her patented inventions.

Latest Patents

Nandini holds a patent for an insulin formulation with a stable basal release profile. This formulation, composed of insulin glargine, injectable zinc, and injectable iron compounds, is designed for subcutaneous, intradermal, or intramuscular administration. The unique aspect of this formulation is its ability to form a precipitate of insulin following injection, which allows for a slow release of basal insulin over a period of 12 to 24 hours.

Career Highlights

Nandini Kashyap has been instrumental in advancing insulin delivery systems. Her work at Biodel Inc. has positioned her as a key player in the pharmaceutical industry. With her innovative approach, she has contributed to the development of more effective diabetes treatments.

Collaborations

Throughout her career, Nandini has collaborated with notable professionals in her field, including Roderike Pohl and Robert Hauser. These partnerships have enhanced her research and development efforts, leading to groundbreaking advancements in insulin formulations.

Conclusion

Nandini Kashyap's contributions to insulin formulation represent a significant advancement in diabetes management. Her innovative work continues to impact the lives of many patients, showcasing her commitment to improving healthcare solutions.